QUALITY-OF-LIFE AND ANTIHYPERTENSIVE DRUGS IN THE ELDERLY

被引：9

作者：

FLETCHER, A

BULPITT, C

机构：

[1] Epidemiology Research Unit, Division of Geriatric Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, W12 OHS, Du Cane Road

来源：

AGING-CLINICAL AND EXPERIMENTAL RESEARCH | 1992年 / 4卷 / 02期

关键词：

ANTIHYPERTENSIVE DRUGS; ELDERLY; QUALITY OF LIFE;

D O I：

10.1007/BF03324077

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Hypertension is common in the elderly with estimates of around 10-20% showing a sustained level of pressure, either systolic (greater-than-or-equal-to 160 mmHg), or diastolic (greater-than-or-equal-to 90 mmHg) or both. The benefits of treating subjects with raised diastolic pressure was shown by the trials of the European Working Party on High Blood Pressure in the Elderly (EWPHE), the Hypertension in Elderly Patients in Primary Care (HEP), and the Swedish Trial in Old patients with Hypertension (STOP-Hypertension). Evidence for the benefit of treating isolated systolic hypertension in the elderly was provided in one trial (SHEP: Systolic Hypertension in the Elderly Program), and the results of two others are awaited. However, it is important to provide data on all treatment effects, including adverse reactions as well as benefits. In addition to traditional measures of mortality, morbidity and side effects, the quality of life in patients on antihypertensive treatment should be considered. The methods of measuring quality of life in trials is discussed, and some results presented.

引用

页码：115 / 123

页数：9

共 55 条

[31]

Fletcher A., Chester P.C., Hawkins C.M.A., Latham A.N., Pike L.A., Bulpitt C.J., The effects of verapamil and propranolol on quality of life in hypertension, J. Human Hypertens., 3, pp. 125-130, (1989)

[32]

Fletcher A.E., Bulpitt C.J., Hawkins C.M., Quality of life on antihypertensive therapy: a randomised double blind controlled trial of captopril and atenolol, J Hypertens., 8, pp. 463-466, (1990)

[33]

Werning C., Weitz T., Ludwig B., Assessment of Indapamide in Elderly Hypertensive Patients with Special Emphasis on Well-Being, Am. J. Med., 84, 1 B, pp. 104-108, (1988)

[34]

Mossey J.M., Shapiro E., Self-rated health: a predictor of mortality among the elderly, Am. J. Public Health, 72, pp. 800-808, (1982)

[35]

Kaplan G.A., Camacho T., Perceived health and mortality: a nine year follow-up of the human population laboratory cohort, Am. J. Epidemiol., 117, pp. 292-304, (1983)

[36]

Grand A., Grosclaude P., Bocquet H., Pous J., Albardee J.L., Disability, psychosocial factors and mortality among the elderly in a rural French population, J. Clin. Epidemiol., 43, pp. 773-782, (1990)

[37]

Bulpitt C.J., Dollery C.T., Carne S., A symptom questionnaire for hypertensive patients, J. Chronic Dis., 27, pp. 309-323, (1974)

[38]

Bulpitt C.J., Dollery C.T., Came S., Change in symptoms of hypertensive patients after referral to hospital clinic, Br. Heart J., 38, pp. 121-128, (1976)

[39]

Bergner M., Bobbit R.A., Carter W.B., Gilson B.S., The Sickness Impact Profile: development and final revision of a health status measurement, Med. Care, 19, pp. 787-805, (1981)

[40]

Fanshel S., Bush J.W., A health status index and its application to health services out-come, Oper. Res., 18, pp. 1021-1066, (1970)

← 1 2 3 4 5 6 →